Remove 2025 Remove Portfolio Remove Public Trading
article thumbnail

10-23-2023 Newsletter: Why Take-Private Dealmaking Remains Attractive for PE Investors

OfficeHours

First, private equity identifies the publicly traded company they believe is undervalued or could perform better as a private entity without the pressures of being a public entity (e.g. OfficeHours Headhunter 101 Doc 10-15 Headhunters control the process…download our 101 Doc to learn more about them!

Investors 130
article thumbnail

Technology Services Mergers Update – Q1 2024

Solganick & Co.

Solganick expects M&A deals to increase in the technology services sector for the remainder of 2024 and continuing into 2025. Private equity buyers have opted to acquire systems integration businesses almost exclusively through their established portfolio companies, or add-on’s. of all transactions through YTD.

Mergers 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2025 Could Be the Year of the Retina Practice Deal

Focus Investment Banking

While questions around the ultimate buyers of these organizations have been building, the sale of RCA, the largest retina practice portfolio in the U.S., The acquisition of RCA by Cencora is not the only indication that 2025 may be a great year for physician-owners of retina practices to pursue a sale.

article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

billion kicking off 2025 with a bang, will the pounds go back on in the new year? Below we take a look at drivers of these dynamics over the past year and offer our predictions for whats to come in 2025. With J&Js announced deal to acquire Intra-Cellular Therapies for $14.6

M&A 64
article thumbnail

Momentum Builds for Ophthalmology Recapitalizations

Focus Investment Banking

Overcoming Marketplace Uncertainty Rising interest rates introduced a difficult environment for private equity recapitalizations (where private equity groups sell a portfolio company to another buyer), so few of the older PE-backed ophthalmology organizations traded hands over the last few years.

article thumbnail

Dogecoin Cash, Inc. ($CBDS) Expands into Meme Coin Market with Formation of MEME COINS Inc.

Global Newswire by Notified: M&A

MESQUITE, NV, March 10, 2025 (GLOBE NEWSWIRE) -- March 10, 2025 Mesquite, NV Dogecoin Cash, Inc. CBDS), a publicly traded leader in blockchain innovation, is excited to announce its strategic expansion into the rapidly growing meme coin market. CBDS and MEME COINS Inc. Formation of MEME COINS Inc.